Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217327 · ClinicalTrials.gov registry record
The DistaSense VITALS Study
A clinical trial of Detection of Heart Rate and Respiratory Rate, sponsored by Life Detection Technologies.
- Recruiting
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT07217327 is a study of Detection of Heart Rate and Respiratory Rate that is actively recruiting participants, run by Life Detection Technologies. The registered enrollment target is 20 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07217327, a study of Detection of Heart Rate and Respiratory Rate, is actively recruiting participants, sponsored by Life Detection Technologies.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST DistaSense and Polysomnography
Study Locations (2)
Missouri
- Clayton Sleep Institute - St Louis
Ohio
- CTI Clinical Research Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-08-13 |
| Est. Completion | 2025-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217327
The ClinicalTrials.gov registry entry for NCT07217327 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Life Detection Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Detection of Heart Rate and Respiratory Rate appearing as the primary indexed condition, and to 1 intervention - of which DistaSense and Polysomnography is the first listed.
NCT07217327 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Missouri, Ohio.
Frequently Asked Questions
What is clinical trial NCT07217327 about?
NCT07217327 is a clinical study titled "The DistaSense VITALS Study". A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.
What is the current status of trial NCT07217327?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-08-13. Estimated completion is 2025-11.
What conditions does trial NCT07217327 study?
This clinical trial studies the following conditions: Detection of Heart Rate and Respiratory Rate.
What interventions are being tested in trial NCT07217327?
The interventions under investigation include: DistaSense and Polysomnography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07217327?
This trial is sponsored by Life Detection Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217327 being conducted?
This trial has 2 study locations across Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.